EPHA2 and nonpapillary renal cell carcinoma: These data revealed that the tumorigenic properties and microvessel density of the experimental group were significantly reduced, suggesting that RSK4 is essential for ccRCC invasion via the activation of RUNX1-EPHA2-VEGF-mediated angiogenesis (Figure 5g).